Literature DB >> 25429512

Sulfation of phenylephrine by the human cytosolic sulfotransferases.

Akihiro Yamamoto, Jiwan Kim, Ming-Yih Liu, Katsuhisa Kurogi, Yoichi Sakakibara, Masahito Suiko, Ming-Cheh Liu1.   

Abstract

Previous studies had demonstrated that sulfation constituted a major pathway for the metabolism of phenylephrine in vivo. The current study was designed to identify the major human SULT(s) responsible for the sulfation of phenylephrine. Of the twelve human SULTs analyzed, SULT1A3 displayed the strongest sulfating activity toward phenylephrine. The enzyme exhibited a pH optimum spanning 7 - 10.5. Kinetic analysis revealed that SULT1A3- mediated sulfation of phenylephrine occurred in the same order of magnitude compared with that previously reported for SULT1A3-mediated sulfation of dopamine. Moreover, sulfation of phenylephrine was shown to occur in HepG2 cells under metabolic setting. Collectively, these results provided useful information concerning the biochemical basis underlying the metabolism of phenylephrine in vivo as previously reported.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25429512     DOI: 10.2174/1872312808666141127113715

Source DB:  PubMed          Journal:  Drug Metab Lett        ISSN: 1872-3128


  1 in total

1.  Impact of SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of phenylephrine and salbutamol by human SULT1A3 allozymes.

Authors:  Ahsan F Bairam; Mohammed I Rasool; Fatemah A Alherz; Maryam S Abunnaja; Amal A El Daibani; Saud A Gohal; Eid S Alatwi; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Pharmacogenet Genomics       Date:  2019-07       Impact factor: 2.089

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.